Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone

American Journal of Obstetrics and Gynecology

Volumn 170, Issue 5, 1994, Pages 1213-1223

  Woodruff, J Donald ^a   Pickar, James H ^a  

^a NONE   (United States)

Author keywords

conjugated estrogens; Estrogen replacement therapy; hormone replacement therapy; medroxyprogesterone acetate; menopause, endometrial hyperplasia; Premarin; progestin

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIUM HYPERPLASIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

AGED; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOMETRIAL HYPERPLASIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; INCIDENCE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0028244156     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(94)70129-6     Document Type: Article

References (17)

1. Hormone therapy to prevent disease and prolong life in postmenopausal women
2. A risk-benefit assessment of estrogen therapy in postmenopausal women
3. The cancer question: an overview of recent epidemiologic and retrospective data
4. The benefits and risks of hormone replacement therapy: an epidemiologic overview
5. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium
6. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints
7. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis
8. Long-term consequences of estrogen and estrogen-progestin replacement
9. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy
10. The minimum effective dose of estrogen for prevention of postmenopausal bone loss
11. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy
12. Continuous estrogen/progestin therapy in menopause